MG, Q., L, C., FP, R., V, C., L, F., A, Z., . . . Investigators, O. B. O. P. C. (2024). Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV). Viruses, 16(5), . https://doi.org/10.3390/v16050682
Chicago Style (17th ed.) CitationMG, Quaranta, et al. "Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV)." Viruses 16, no. 5 (2024). https://doi.org/10.3390/v16050682.
MLA (9th ed.) CitationMG, Quaranta, et al. "Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV)." Viruses, vol. 16, no. 5, 2024, https://doi.org/10.3390/v16050682.